Enliven Therapeutics Inc (ELVN) Annual Balance Sheets

Annual · GAAP · USD millions
Access ELVN quarterly Balance Sheets →
From Enliven Therapeutics Inc through Dec 31 2021, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent98.90
Marketable Securities, Current SH363.73
Cash & Short-term Investments461.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current12.26
Total Current Assets474.88
Equipment/Property/Plant Net0.03
Other Assets, Noncurrent1.26
Restricted Cash Current-
Contingent Value Right Asset-
Operating Lease Right Of Use Asset0.38
Total Assets476.17
Liabilities
Accounts Payable, Current AC2.16
Other Liabilities, Current0.00
Total Current Liabilities16.57
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Accrued Expenses And Other Current Liabilities14.41
Total Liabilities16.57
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock806.37
Retained Earnings / Accumulated Deficit-347.17
Other Equity0.33
Common Stockholder's Equity459.60
Total Stockholder's Equity459.60
Liabilities & Stockholder's Equity476.17
4 historic quarters locked

Sign in to unlock the full Enliven Therapeutics Inc balance sheet history.

About Enliven Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-088232

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License